
|Videos|April 14, 2017
New Parkinson Disease Treatment
Author(s)Bobby Lazzara, MD
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Advertisement
There is now another option for patients with Parkinson disease. The
In patients experiencing “off” episodes, safinamide has been shown in two clinical trials to be efficacious in reducing involuntary movement and improving motor function scores.
The most common side effects are falls, nausea, insomnia, and dyskinesia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Advanced Therapy with Apomorphine Pump in Parkinson’s Disease
2
SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study Update
3
Inside the Development of ISSCR’s New Parkinson Disease Stem Cell Program
4
Managing OFF Time in Parkinson’s Disease
5













